LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
35 funds hold it · Insiders net buying
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 28, 2026
Financial period
Q3 2026
Earnings per share
$1.20 expected
Revenue
$5.35B expected
Estimates as of Nov 10, 2026
EPS expected
$1.53 to $1.60
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 28, 2026 | $1.34est. $1.20 | +11.28%beat | $5.51Best. $5.35B+3.01% | +7.2%from $5.14B |
| Jun 30, 2026Reported Jul 29, 2026 | $1.13est. $1.04 | +9.09%beat | $5.29BCompany release | +5.8%from $5.01B |
| Mar 31, 2026Reported Apr 29, 2026 | $0.99est. $1.05 | -5.71%miss | $5.13BSEC filing | +7.4%from $4.78B |
| Dec 31, 2025Reported Feb 4, 2026 | $1.44est. $1.40 | +2.99%beat | $5.70BAlpha Vantage | +7.1%from $5.32B |
| Sep 30, 2025Reported Oct 29, 2025 | $1.07est. $1.05 | +1.90%beat | $5.14BSEC filing | +5.8%from $4.86B |
| Jun 30, 2025Reported Jul 30, 2025 | $1.06est. $0.92 | +15.22%beat | $5.01BSEC filing | +3.5%from $4.84B |
| Mar 31, 2025Reported Apr 30, 2025 | $1.01est. $0.91 | +10.99%beat | $4.78BSEC filing | +2.7%from $4.65B |
| Dec 31, 2024Reported Feb 13, 2025 | $1.57est. $1.26 | +24.60%beat | $5.32BAlpha Vantage | +2.2%from $5.21B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.70B | $5.13B | $5.29B | $5.51B |
| Cost of what it sold | $3.44B | $3.15B | $3.12B | $3.29B |
| Gross profit | $2.26B | $1.98B | $2.18B | $2.22B |
| What it spent | ||||
| Research and development | $323.0M | $345.0M | $323.0M | $320.0M |
| Sales and admin | $1.11B | $1.12B | $1.12B | $1.10B |
| Total operating expenses | $1.43B | $1.46B | $1.44B | $1.42B |
| What was left | ||||
| Operating profit | $827.0M | $515.0M | $739.0M | $804.0M |
| Interest on debt | $105.0M | $96.0M | $114.0M | $122.0M |
| Profit before tax | $821.0M | $505.0M | $693.0M | $752.0M |
| Tax | $219.0M | $94.0M | $119.0M | $129.0M |
| Net profit | $589.0M | $389.0M | $573.0M | $614.0M |
| EBITDA | $1.07B | $755.0M | $953.0M | $1.04B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates
NeutralNov 10GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
BullishNov 10Hallador Energy (HNRG) Q3 2026 Earnings Call Transcript
NeutralNov 1012,505 Medtronic PLC $MDT Shares Purchased by Alps Advisors Inc.
NeutralNov 10RadNet posts revenue growth in Q3
Leans bullishNov 9Stryker announces intention to nominate Jim Davis to board of directors
Leans bullishNov 9Tandem Diabetes names former GE HealthCare exec as president and CEO
NeutralNov 9How Sentara adapted clinical AI for case management
Leans bullishNov 932 macro signals shaping GEHC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
